Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo

Onkologie

Volumn 32, Issue 6, 2009, Pages 337-343

  Brozovic, Gordana ^a   Orsolic, Nada ^b   Knezevic, Fabijan ^a   Knezevic, Anica Horvat ^b   Benkovic, Vesna ^b   Sakic, Katarina ^c   Hrgovic, Zlatko ^d,g   Bendelja, Kreso ^e   Fassbender, Walter J ^f  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c KBC Zagreb   (Croatia)

^d University Hospital JJ Strossmayer   (Croatia)

^e INSTITUTE OF IMMUNOLOGY   (Croatia)

^f Hospital Zum Hl Geist   (Germany)

^g NONE   (Germany)

Author keywords

Cisplatin; Cytotoxicity; Ehrlich ascites tumour (EAT); Genotoxicity; Inhalation anaesthetics; Mice

Indexed keywords

CISPLATIN; DNA; HALOTHANE; ISOFLURANE; SEVOFLURANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASCITES; CELL DAMAGE; CELL DEATH; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; EHRLICH ASCITES TUMOR CELL; FLOW CYTOMETRY; GENOTOXICITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE;

ANESTHETICS, INHALATION; ANIMALS; APOPTOSIS; CARCINOMA, EHRLICH TUMOR; CISPLATIN; DNA DAMAGE; DRUG INTERACTIONS; MALE; MICE; TREATMENT OUTCOME;

EID: 67650269867     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218066     Document Type: Article

References (26)

1. Halliwell B, Cross CE: Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 1994;102(suppl 10):5-12.
2. Baden JM, Simmon VF: Mutagenic effects of inhalational anesthetics. Mutat Res 1980;75:169-189.
3. Rozgaj R, Kašuba V, Brozovič G, Jazbec A: Genotoxic effects of anaesthetics in operating theatre personnel evaluated by the comet assay and micronucleus test. Int J Hyg Environ Health 2007;212:11-17.
4. Ceelen WP, Hesse U, de Hemptinne B, Pattyn P: Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000;87:1006-1015.
5. Zaniboni A, Prabhu S, Audisio RA: Chemotherapy and anaesthetic drugs: too little is known. Lancet Oncol 2005;6:176-181.
6. Beijnen JH, Schellens JHM: Drug interactions in oncology. Lancet Oncol 2004;5:489-496.
7. Kvolik S, Glavas-Obrovac L, Sakic K, Margaretic D, Karner I: Anaesthetic implications of anticancer chemotherapy. Eur J Anaesthesiol 2003;20:1-13.
8. Moudgil GC, Singal DP: Halothane and isoflurane enhance melanoma tumour metastasis in mice. Can J Anaesth 1997;44:90-94.
9. Karabiyik L, Şardaş S, Polat U, Kocaba Ş NA, Karakaya AE: Comparison of genotoxicity of sevoflurane and isoflurane in human lymphocytes studied in vivo using the comet assay. Mutat Res 2001;492: 99-107.
10. Sardas S, Izdes S, Ozcagli E, Kanbak O, Kadioglu E: The role of antioxidant supplementation in occupational exposure to waste anaesthetic gases. Int Arch Occup Environ Health 2006;80:154-159.
11. JaloszyŃski P, Ta̧drowska M, Kujawski M, Wa̧sowicz M, Szulc R, Szyfter K: Genotoxicity of inhalation anesthetics (halothane, isoflurane and sevoflurane) in human lymphocytes studied in vivo and in vitro. Neoplasma 1999;46:20-22.
12. Pleuvry A: Anaesthetic relevance of drugs used to treat cancer. Anaesth Intensive Care Med 2006;7: 189-192.
13. Hegarty M, Chisholm D: Chemotherapy and anaesthesia. Curr Anaesth Crit Care 2002;13:168-174.
14. Kvolik S, Glavas-Obrovac L, Bares V, Karner I: Effects of inhalation anesthetics halothane, sevoflu-rane, and isoflurane on human cell lines. Life Sci 2005;77:2369-2383.
15. Topouzova-Hristova T, Daza P, Garcia-Herdugo G, Stephanova E: Volatile anaesthetic halothane causes DNA damage in A549 lung cells. Toxicol In Vitro 2006;20:585-593.
16. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S: Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003;97:1331-1339.
17. Hack G, Karzel K: Suspension cultures of Ehrlich ascites tumor cells test system for the study of cytotoxic effects of anaesthetics. Anaesthesist 1981;30: 88-94.
18. Singh NP, Mc Coy MT, Tice RR, Schneider EL: A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-191.
19. Collins AR: The comet assay for DNA damage and repair: Principles, applications, and limitations. Mol Biotechnol 2004;26:249-261.
20. Alleva R, Tomasetti M, Solenghi MD, Stagni F, Gamberini F, Bassi A, Fornasari PM, Fanelli G, Borghi B: Lymphocyte DNA damage precedes DNA repair or cell death after orthopaedic surgery under general anaesthesia. Mutagenesis 2003;18: 423-428.
21. Epe B: DNA damage profiles induced by oxidizing agents. Rev Physiol Biochem Pharmacol 1996;127: 223-249.
22. Hoffmann JS, Johnson NP, Villani G: Conversion of monofunctional DNA adducts of cis-diaminedichloroplatinum (II) to bifunctional lesions. Effect on the in vitro replication of single-stranded DNA by Escherichia coli DNA polymerase I and eukaryotic DNA polymerases alpha. J Biol Chem 1989;264: 15130-15135.
23. Bouwman RA, van't Hof FN, de Ruijter W, van Beek-Harmsen BJ, Musters RJ, de Lange JJ, Boer C: The mechanism of sevoflurane-induced cardioprotection is independent of the applied ischaemic stimulus in rat trabeculae. Br J Anaesth 2006;97: 307-314.
24. Nielsen DL: Mechanisms and functional aspects of multidrug resistance in Ehrlich ascites tumour cells. Dan Med Bull 2004;51:393-414.
25. Kevin LG, Novalija E, Stowe DF: Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anesthesia practice. Anesth Analg 2005;101:1275-1287.
26. Matsuoka H, Kurosawa S, Horinouchi T, Kato M, Hashimoto Y: Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro. Anesthesiology 2001;95:1467-1472.